FROM SWEDEN TO THE WORLD
Mercodia is a Swedish life science company and the premier bioanalytical CRO specialized in cardiometabolic diseases. For over 30 years, we have provided proprietary immunoassay solutions, along with scientific, bioanalytical, and regulatory expertise, to accelerate drug development programs targeting diabetes, obesity, and related cardiorenal-metabolic conditions.
We understand the unique complexities of these diseases because they are the foundation of our expertise. This deep focus allows us to integrate seamlessly as your dedicated scientific extension, helping you achieve your development goals faster.
Our offering combines three core business areas: gold-standard immunoassays, expert bioanalytical services, and scalable contract manufacturing. All in one streamlined solution. From our GLP-compliant laboratories in Europe and the US, we support preclinical through clinical phases with reliable, actionable data.
Vision & Mission
Vision | Our vision is to improve human health through the use of our products and services by scientists worldwide. From our headquarters in Uppsala, Sweden, we distribute products and services across the globe.
Mission | Mercodia develops tools to advance life science and pharmaceutical research. We are committed to delivering products and services with the highest reliability and accuracy, becoming a trusted and valued partner to customers worldwide.
OUR HISTORY
Mercodia was founded 1991 in Uppsala by Erling Holmlund, a chemist and entrepreneur from northern Sweden. Erling’s extensive knowledge in the field stems from almost 20 years of experience in immunoassay development within diabetes and cardiovascular disease at Pharmacia Diagnostics
With the stringent quality system inherited from Pharmacia Diagnostics, the initial business concept of Mercodia was to develop high quality ELISAs for use in human diagnostics. The increased demand from pharmaceutical and academic research for reliable assays that ensure reproducible results created an interest from researchers around the world for Mercodias’s products.
We expand our global footprint in bioanalytical services with a local presence in the largest market.
OUR FUTURE
Continue to grow the bioanalytical service offering by boosting our analytical capabilities in our US-based service laboratory
Continuously expand with new technology platforms to meet customer demands through partnerships
Continuous expansion of our portfolio of high-quality assays, and to become the preferred partner for bioanalytical and OEM services for life science and pharmaceutical industry
join our journey
Are you driven by science, innovation, and the desire to make a meaningful impact on global health? At Mercodia, we’re always looking for curious minds and committed professionals to grow with us.
If you’re interested in joining our team, we encourage you to explore our current job openings or send us your CV. Together, let’s improve human health!
Quality policy
Mercodia will offer customers products and services with well-defined quality and high precision of delivery. Mercodia can offer customers:
- Immunoassay kits (IVD and RuO)
- Assay development
- Manufacturing services
- Sample analysis services
To ensure success, Mercodia’s work must follow clear, efficient, and secure processes. The CEO is responsible for ensuring the quality management system meets requirements, complies with regulations, and is continuously updated.
Let’s meet the future together
Together, we’re shaping a future where sustainable business isn’t just a choice but a necessity for a thriving planet and society. At Mercodia, we are committed to reducing our environmental impact, striving to leave behind a planet capable of meeting the needs of future generations. We prioritize sustainability and responsible corporate behavior through our commitment to Environmental, Social, and Governance (ESG) principles.
LATEST NEWS
Immunoassays for cardiometabolic biomarker measurement Cardiometabolic diseases, including diabetes, obesity, and cardiovascular conditions, are among the most pressing global health challenges. At Me…
READ MORE
Designed for Human Insulin Detection We are proud to introduce the Insulin MBeads Assay (10-1371-01), a high-throughput solution for accurate and efficient quantification of human insulin in vitro. De…
READ MORE
In 2024, we achieved 33 percent growth, bringing our total growth to 70 percent over the past three years. This reflects our long-term focus on delivering high-quality bioanalytical services and innov…
READ MORE